drug stores

Will the stock market drop 20% or 48% from the peak? Here's the key factor, says this strategist.

Will the stock market drop 20% or 48% from the peak? Here’s the key factor, says this strategist.

“Is the economy under control or is it spiraling out of control? That’s the million-dollar question traders continue arguing over,” sums up CrackedMarket blogger Jani Ziedins. Clearly, the latter argument prevailed — again — after Wall Street’s worst day in two years, and futures hinting of more pain for Thursday. Among the gloomsters, Guggenheim’s Scott …

Will the stock market drop 20% or 48% from the peak? Here’s the key factor, says this strategist. Read More »

Why this investor who paid $650,000 to lunch with Buffett isn't buying or selling stocks right now

Why this investor who paid $650,000 to lunch with Buffett isn’t buying or selling stocks right now

It’s 13-F season, and you’re not going to find many like Guy Spier’s Aquamarine Capital in the first quarter —- zero buys, zero sells. “Pathetic, isn’t it,” quips Spier in an interview. Spier says he feels less pressure to trade for trading sake after he stopped charging management fees. He also cites the possibly apocryphal …

Why this investor who paid $650,000 to lunch with Buffett isn’t buying or selling stocks right now Read More »

Gloomy Goldman offers 20 'safety' stocks with valuations below the previous 2 bear markets

Gloomy Goldman offers 20 ‘safety’ stocks with valuations below the previous 2 bear markets

It’s tight quarters in Wall Street’s bear sleuth these days. Goldman Sachs just downgraded their 2022 U.S. growth forecast (to 2.4% from 2.6%) and 2023 (to 1.6% from 2.2%), as senior chairman Lloyd Blankfein warned of “very, very high” risks for a U.S. recession. “If I were running a big company, I would be very …

Gloomy Goldman offers 20 ‘safety’ stocks with valuations below the previous 2 bear markets Read More »